|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06660 AIM VACCINE
Nominal 
6.560 -0.400 (-5.747%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 1,187,468 | -6.060% | 1,264,073 | 1,570,129 | 1,637,970 | 951,648 |
| Cost of Sales | (286,452) | 21.165% | (236,414) | (275,429) | (283,882) | (218,803) |
| Gross Profit | 901,016 | -12.323% | 1,027,659 | 1,294,700 | 1,354,088 | 732,845 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (61,091) | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (1,727,854) | 6248.903% | (27,215) | (7,981) | (826) | 2,103 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (2,270,645) | 422.991% | (434,165) | (606,703) | 485,886 | 156,761 | |
| Taxation | 320,404 | 57.420% | 203,535 | (69,170) | (85,472) | (36,947) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 649,236 | -- | (88,971) | (16,901) | (21,127) | (2,408) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (1,301,005) | 307.072% | (319,601) | (692,774) | 379,287 | 117,406 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 33,125 | 120.848% | 14,999 | (74) | 5,005 | 7,114 |
| Depreciation & Amortisation | 174,697 | 4.960% | 166,441 | 144,291 | 128,342 | 109,440 |
| Directors' Emoluments | 8,035 | -89.760% | 78,463 | 902,616 | 4,710 | 4,716 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -107.000 | 296.296% | -27.000 | -60.000 | -- | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.137) | -- | (0.092) | 0.080 | -- | -- |
| NBV per share ($) | 3.008 | -- | 4.096 | -- | -- | -- |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -139,254,000 |
| %Change | -44.380% |
| EPS / (LPS) | RMB -0.110 |
| NBV Per Share (¥) | RMB 2.893 |